ZIPRASIDONE MESYLATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ziprasidone mesylate and what is the scope of patent protection?
Ziprasidone mesylate
is the generic ingredient in two branded drugs marketed by Viatris, Gland Pharma Ltd, and MSN, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Seven suppliers are listed for this compound.
Summary for ZIPRASIDONE MESYLATE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 56 |
Clinical Trials: | 1 |
Patent Applications: | 277 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ZIPRASIDONE MESYLATE? | ZIPRASIDONE MESYLATE excipients list |
DailyMed Link: | ZIPRASIDONE MESYLATE at DailyMed |
Recent Clinical Trials for ZIPRASIDONE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yang Fude | Phase 4 |
Pfizer | Phase 4 |
Pharmacology for ZIPRASIDONE MESYLATE
Drug Class | Atypical Antipsychotic |
Anatomical Therapeutic Chemical (ATC) Classes for ZIPRASIDONE MESYLATE
US Patents and Regulatory Information for ZIPRASIDONE MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gland Pharma Ltd | ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 211908-001 | Dec 26, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Msn | ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 216091-001 | Sep 15, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZIPRASIDONE MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.